Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million
Go back to Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million| (NASDAQ: AXSM) | Delayed: 206.78 -0.99 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $207.77 | 52 Week High | $15.74 | |||
| Open | $207.00 | 52 Week Low | $5.37 | |||
| Day High | $208.09 | P/E | N/A | |||
| Day Low | $205.52 | EPS | $0.00 | |||
| Volume | 12,213 | |||||

